PRA Health Sciences, Inc. Operating Income
PRA Health Sciences, Inc. reported Operating Income of $69.51 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-04-29.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2021-04-29
- PRA Health Sciences, Inc. operating income (loss) for the quarter ending 2021-03-31 was $69.51M, a 10.02% increase year-over-year.
- PRA Health Sciences, Inc. operating income (loss) for the quarter ending 2020-12-31 was $97.12M, a 4.22% decline year-over-year.
- PRA Health Sciences, Inc. operating income (loss) for the quarter ending 2020-09-30 was $124.16M, a 29.62% increase year-over-year.
- PRA Health Sciences, Inc. operating income (loss) for the quarter ending 2020-06-30 was $43.63M, a 50.43% decline year-over-year.
- PRA Health Sciences, Inc. operating income (loss) for fiscal 2020 was $328.09M, a 9.85% decline from fiscal 2019.
- PRA Health Sciences, Inc. operating income (loss) for fiscal 2019 was $363.93M, a 29.37% increase from fiscal 2018.
- PRA Health Sciences, Inc. operating income (loss) for fiscal 2018 was $281.31M, a 59.63% increase from fiscal 2017.
- PRA Health Sciences, Inc. operating income (loss) for fiscal 2017 was $176.22M, a 8.55% increase from fiscal 2016.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | $69.51M 10-Q · filed 2021-04-29 | $166.63M derived: sum of 2 quarters · filed 2021-04-29 | $290.79M derived: sum of 3 quarters · filed 2021-04-29 | $334.42M derived: sum of 4 quarters · filed 2021-04-29 | |||
| 2020-12-31 | $97.12M 10-K · filed 2021-02-24 | $221.28M derived: sum of 2 quarters · filed 2021-02-24 | $264.91M derived: sum of 3 quarters · filed 2021-02-24 | $328.09M 10-K · filed 2021-02-24 | |||
| 2020-09-30 | $124.16M 10-K · filed 2021-02-24 | $167.79M derived: sum of 2 quarters · filed 2021-02-24 | $230.97M 10-Q · filed 2020-11-05 | $332.37M derived: sum of 4 quarters · filed 2021-04-29 | |||
| 2020-06-30 | $43.63M 10-K · filed 2021-02-24 | $106.81M 10-Q · filed 2020-08-07 | $208.21M derived: sum of 3 quarters · filed 2021-04-29 | $304.00M derived: sum of 4 quarters · filed 2021-04-29 | |||
| 2020-03-31 | $63.18M 10-Q · filed 2021-04-29 | $164.58M derived: sum of 2 quarters · filed 2021-04-29 | $260.37M derived: sum of 3 quarters · filed 2021-04-29 | $348.38M derived: sum of 4 quarters · filed 2021-04-29 | |||
| 2019-12-31 | $101.40M 10-K · filed 2021-02-24 | $197.19M derived: sum of 2 quarters · filed 2021-02-24 | $285.20M derived: sum of 3 quarters · filed 2021-02-24 | $363.93M 10-K · filed 2021-02-24 | |||
| 2019-09-30 | $95.79M 10-K · filed 2021-02-24 | $183.80M derived: sum of 2 quarters · filed 2021-02-24 | $262.53M 10-Q · filed 2020-11-05 | $359.28M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $88.01M 10-K · filed 2021-02-24 | $166.74M 10-Q · filed 2020-08-07 | $263.49M derived: sum of 3 quarters · filed 2021-02-24 | $302.30M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | $78.72M 10-K · filed 2021-02-24 | $175.48M derived: sum of 2 quarters · filed 2021-02-24 | $214.29M derived: sum of 3 quarters · filed 2021-02-24 | $288.09M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $96.76M 10-K · filed 2020-02-21 | $135.57M derived: sum of 2 quarters · filed 2020-02-21 | $209.36M derived: sum of 3 quarters · filed 2020-02-21 | $281.31M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $38.81M 10-K · filed 2020-02-21 | $112.61M derived: sum of 2 quarters · filed 2020-02-21 | $184.56M 10-Q · filed 2019-10-31 | $188.17M derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2018-06-30 | $73.80M 10-K · filed 2020-02-21 | $145.74M 10-Q · filed 2019-08-01 | $149.36M derived: sum of 3 quarters · filed 2020-02-21 | $207.13M derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2018-03-31 | $71.95M 10-K · filed 2020-02-21 | $75.56M derived: sum of 2 quarters · filed 2020-02-21 | $133.34M derived: sum of 3 quarters · filed 2020-02-21 | $198.19M derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2017-12-31 | $3.61M 10-K · filed 2019-02-28 | $61.39M derived: sum of 2 quarters · filed 2019-02-28 | $126.24M derived: sum of 3 quarters · filed 2019-02-28 | $176.22M 10-K · filed 2020-02-21 | |||
| 2017-09-30 | $57.78M 10-K · filed 2019-02-28 | $56.78M 10-Q · filed 2017-10-26 | $122.63M derived: sum of 2 quarters · filed 2019-02-28 | $172.61M 10-Q · filed 2018-11-06 | $171.69M 10-Q · filed 2017-10-26 | $210.85M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | $64.85M 10-K · filed 2019-02-28 | $64.89M 10-Q · filed 2017-08-08 | $114.84M 10-Q · filed 2018-08-02 | $114.91M 10-Q · filed 2017-08-08 | $153.08M derived: sum of 3 quarters · filed 2019-02-28 | $207.89M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-03-31 | $49.99M 10-K · filed 2019-02-28 | $50.03M 10-Q · filed 2017-04-26 | $88.23M derived: sum of 2 quarters · filed 2019-02-28 | $143.04M derived: sum of 3 quarters · filed 2019-02-28 | $193.39M derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2016-12-31 | $38.24M 10-K · filed 2018-02-22 | $93.06M derived: sum of 2 quarters · filed 2018-02-22 | $143.40M derived: sum of 3 quarters · filed 2018-02-22 | $162.35M 10-K · filed 2019-02-28 | |||
| 2016-09-30 | $54.81M 10-K · filed 2018-02-22 | $105.16M derived: sum of 2 quarters · filed 2018-02-22 | $124.11M 10-Q · filed 2017-10-26 | $167.97M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2016-06-30 | $50.35M 10-K · filed 2018-02-22 | $69.29M 10-Q · filed 2017-08-08 | $113.16M derived: sum of 3 quarters · filed 2018-02-22 | $162.33M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2016-03-31 | $18.95M 10-K · filed 2018-02-22 | $62.81M derived: sum of 2 quarters · filed 2018-02-22 | $111.99M derived: sum of 3 quarters · filed 2018-02-22 | $150.31M derived: sum of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | $43.86M 10-K · filed 2017-02-23 | $93.04M derived: sum of 2 quarters · filed 2017-02-23 | $131.36M derived: sum of 3 quarters · filed 2017-02-23 | $164.30M 10-K · filed 2018-02-22 | |||
| 2015-09-30 | $49.18M 10-K · filed 2017-02-23 | $87.50M derived: sum of 2 quarters · filed 2017-02-23 | $120.44M 10-Q · filed 2016-11-03 | $132.14M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-06-30 | $38.32M 10-K · filed 2017-02-23 | $71.26M 10-Q · filed 2016-07-29 | $82.97M derived: sum of 3 quarters · filed 2017-02-23 | $99.94M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | $32.94M 10-K · filed 2017-02-23 | $44.64M derived: sum of 2 quarters · filed 2017-02-23 | $61.62M derived: sum of 3 quarters · filed 2017-02-23 | $79.05M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | $11.71M 10-K · filed 2016-02-25 | $28.68M derived: sum of 2 quarters · filed 2016-02-25 | $46.12M derived: sum of 3 quarters · filed 2016-02-25 | $56.84M 10-K · filed 2017-02-23 | |||
| 2014-09-30 | $16.97M 10-K · filed 2016-02-25 | $34.41M derived: sum of 2 quarters · filed 2016-02-25 | $45.13M 10-Q · filed 2015-11-03 | $22.48M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-06-30 | $17.43M 10-K · filed 2016-02-25 | $17.44M 10-Q · filed 2015-07-28 | $28.16M 10-Q · filed 2015-07-28 | $5.50M derived: sum of 3 quarters · filed 2016-02-25 | |||
| 2014-03-31 | $10.72M 10-K · filed 2016-02-25 | -$11.93M derived: sum of 2 quarters · filed 2016-02-25 | |||||
| 2013-12-31 | -$22.66M 10-K · filed 2016-02-25 |